Pharma Blog Watch
Bayer
vs. Merck KgAA (In the Pipeline) http://www.corante.com/pipeline
In
his humorous entry, blogger Derek Lowe discusses the current squabble between
Bayer and Merck KgAA to acquire Schering AG.
Breast
Cancer Treatment in the Pipeline (The Pharm Voice) http://www.thepharmvoice.com
Aromasin
been identified as an effective treatment the 80 percent of breast cancers known
as oestrogen-positive, but not for the more aggressive HER2 form of the disease.
In her entry, blogger Gloria Gamat writes about the development of the medication.
Continuing Ketek
Woes (Drug Injury Watch) http://www.drug-injury.com
Sanofi-aventis
recently suspended its trial of respiratory tract infection drug Ketek, citing
the possible risk of "severe, life-threatening and in some cases fatal"
liver toxicity. In his entry, blogger Tom Lamb cites the various news reports
spawned by the suspension and anticipates what the FDA's future actions will be
in regard to the medication.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May